A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Chromosomal Microarray, Postnatal Familial Follow-up, ClariSure® Oligo-SNP
Test Code39910
CPT Codes
81479
Preferred Specimen
5 mL whole blood collected in a sodium heparin (green-top) tube
Minimum Volume
Whole blood: 3 mL
Other Acceptable Specimens
Whole blood collected in: Sodium heparin (royal blue-top) tube, sodium heparin lead-free (tan-top) tube, or EDTA (lavender-top) tube • Buccal Swab collected in ORAcollect-Dx OCD-100/OCD-100A • Saliva collected in OGD-500 Oragene Dx collection kit
Instructions
Saliva collected in Oragene 0GD 500 collection kit up to the "fill to" line on the device, do not count bubbles.
Transport Temperature
Room temperature
Specimen Stability
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Room temperature: Preferred
Refrigerated: Acceptable
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received Frozen
Methodology
Oligo-SNP Array
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
A.M. Sets up 7 days a week.
Report Available
Reports in 10 to 12 days.
Clinical Significance
To assist in establishing the clinical significance when a relative's chromosomal microarray study reveals a copy number variant. This test determines the familial presence or absence of a specific CNV identified by chromosomal microarray testing in a proband.